Pfizer has issued a recall for a medication used to treat high blood pressure, along with two generic versions, amid concerns over an impurity that has been linked to increased cancer risk.
, the drugmaker said Monday that six lots of its Accuretic tablets have higher-than-acceptable levels of nitrosamine. One lot of generic quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/hydrochlorothiazide tablets, both distributed by Greenstone, also contain the impurity and are included in the recall.
The release went on to say the hypertension drugs lower blood pressure, reducing the risk of cardiovascular events such as strokes and myocardial infections. “The products have a safety profile that has been established over 20 years of marketing authorization and through a robust clinical program,” the release said. “To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data.”
The company urged patients taking the recalled drugs “to consult with their doctor about alternative treatment options.”©2022 Cox Media Group
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer recalls certain lots of blood pressure medications due to possible cancer-causing impuritiesPfizer is voluntarily recalling certain lots of its blood pressure drug 'Accuretic,' and two other versions, due to potential cancer risk.
Lire la suite »
Pfizer recalls blood pressure drug because of potential carcinogenSome lots of Accuretic as well as generic versions are recalled.
Lire la suite »
Pfizer Recalls Some Blood Pressure Drugs Nationwide Over Potential Cancer RiskPfizer is recalling certain lots of a popular blood pressure drug nationwide as well as two authorized generics distributed directly to patients by a subsidiary because of higher-than-acceptable levels of a nitrosamine linked to potential cancer risk.
Lire la suite »
Pfizer recalls certain lots of blood pressure medications due to possible cancer-causing impuritiesPfizer is voluntarily recalling certain lots of its blood pressure drug 'Accuretic,' and two other versions, due to potential cancer risk.
Lire la suite »
Pfizer recalls blood pressure drugs due to a potential carcinogenPfizer Inc. has issued a voluntary recall of its blood pressure drugs due to excess levels of potentially cancer-causing impurities.
Lire la suite »
Pfizer recalls certain lots of blood pressure medications due to possible cancer-causing impuritiesPfizer is voluntarily recalling certain lots of its blood pressure drug 'Accuretic,' and two other versions, due to potential cancer risk.
Lire la suite »